{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:25Z","timestamp":1786982185479,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2009,6,26]],"date-time":"2009-06-26T00:00:00Z","timestamp":1245974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s12016-009-8154-x","type":"journal-article","created":{"date-parts":[[2009,6,24]],"date-time":"2009-06-24T22:29:59Z","timestamp":1245882599000},"page":"196-200","source":"Crossref","is-referenced-by-count":48,"title":["The Pathogenesis of Neural Injury in Animal Models of the Antiphospholipid Syndrome"],"prefix":"10.1007","volume":"38","author":[{"given":"Aviva","family":"Katzav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joab","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,6,26]]},"reference":[{"key":"8154_CR1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.autrev.2007.11.017","volume":"7","author":"GR Hughes","year":"2008","unstructured":"Hughes GR (2008) Hughes syndrome (the antiphospholipid syndrome): ten clinical lessons. Autoimmun Rev 7:262\u2013266","journal-title":"Autoimmun Rev"},{"key":"8154_CR2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1191\/0961203303lu500oa","volume":"12","author":"A Katzav","year":"2003","unstructured":"Katzav A, Chapman J, Shoenfeld Y (2003) CNS dysfunction in the antiphospholipid syndrome. Lupus 12:903\u2013907","journal-title":"Lupus"},{"key":"8154_CR3","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1191\/0961203303lu496oa","volume":"12","author":"J Sastre-Garriga","year":"2003","unstructured":"Sastre-Garriga J, Montalban X (2003) APS and the brain. Lupus 12:877\u2013882","journal-title":"Lupus"},{"key":"8154_CR4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11239-005-3204-6","volume":"20","author":"RL Brey","year":"2005","unstructured":"Brey RL (2005) Antiphospholipid antibodies in young adults with stroke. J Thromb Thrombolysis 20:105\u2013112","journal-title":"J Thromb Thrombolysis"},{"key":"8154_CR5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/s10165-008-0042-3","volume":"18","author":"CJ Edwards","year":"2008","unstructured":"Edwards CJ, Hughes GR (2008) Hughes syndrome (the antiphospholipid syndrome): 25\u00a0years old. Mod Rheumatol 18:119\u2013124","journal-title":"Mod Rheumatol"},{"key":"8154_CR6","first-page":"556","volume":"19","author":"Y Molad","year":"1992","unstructured":"Molad Y, Sidi Y, Gornish M, Lerner M, Pinkhas J, Weinberger A (1992) Lupus anticoagulant: correlation with magnetic resonance imaging of brain lesions. J Rheumatol 19:556\u2013561","journal-title":"J Rheumatol"},{"key":"8154_CR7","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2214\/ajr.167.6.8956600","volume":"167","author":"JM Provenzale","year":"1996","unstructured":"Provenzale JM, Barboriak DP, Allen NB, Ortel TL (1996) Patients with antiphospholipid antibodies: CT and MR findings of the brain. AJR Am J Roentgenol 167:1573\u20131578","journal-title":"AJR Am J Roentgenol"},{"key":"8154_CR8","first-page":"985","volume":"30","author":"G Sanna","year":"2003","unstructured":"Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Khamashta MA, Mathieu A et al (2003) Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 30:985\u2013992","journal-title":"J Rheumatol"},{"key":"8154_CR9","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1001\/archinte.166.20.2278","volume":"166","author":"MG Tektonidou","year":"2006","unstructured":"Tektonidou MG, Varsou N, Kotoulas G, Antoniou A, Moutsopoulos HM (2006) Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings. Arch Intern Med 166:2278\u20132284","journal-title":"Arch Intern Med"},{"key":"8154_CR10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/rheumatology\/keh532","volume":"44","author":"S Ferreira","year":"2005","unstructured":"Ferreira S, D\u2019Cruz DP, Hughes GR (2005) Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology (Oxford) 44:434\u2013442","journal-title":"Rheumatology (Oxford)"},{"key":"8154_CR11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1196\/annals.1361.088","volume":"1051","author":"G Sanna","year":"2005","unstructured":"Sanna G, Bertolaccini ML, Hughes GR (2005) Hughes syndrome, the antiphospholipid syndrome: a new chapter in neurology. Ann N Y Acad Sci 1051:465\u2013486","journal-title":"Ann N Y Acad Sci"},{"key":"8154_CR12","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(05)63936-0","volume":"350","author":"RA Roubey","year":"1997","unstructured":"Roubey RA, Hoffman M (1997) From antiphospholipid syndrome to antibody-mediated thrombosis. Lancet 350:1491\u20131493","journal-title":"Lancet"},{"key":"8154_CR13","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/01.STR.29.9.1755","volume":"29","author":"D Tanne","year":"1998","unstructured":"Tanne D, Triplett DA, Levine SR (1998) Antiphospholipid-protein antibodies and ischemic stroke: not just cardiolipin any more. Stroke 29:1755\u20131758","journal-title":"Stroke"},{"key":"8154_CR14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/jaut.2000.0426","volume":"15","author":"RL Brey","year":"2000","unstructured":"Brey RL (2000) Differential diagnosis of central nervous system manifestations of the antiphospholipid antibody syndrome. J Autoimmun 15:133\u2013138","journal-title":"J Autoimmun"},{"issue":"Suppl 2","key":"8154_CR15","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1177\/096120339800700216","volume":"7","author":"RL Brey","year":"1998","unstructured":"Brey RL, Escalante A (1998) Neurological manifestations of antiphospholipid antibody syndrome. Lupus 7(Suppl 2):S67\u2013S74","journal-title":"Lupus"},{"key":"8154_CR16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1749-6632.2002.tb04242.x","volume":"966","author":"J Chapman","year":"2002","unstructured":"Chapman J, Shoenfeld Y (2002) Neurological and neuroendocrine-cytokine inter-relationship in the antiphospholipid syndrome. Ann N Y Acad Sci 966:415\u2013424","journal-title":"Ann N Y Acad Sci"},{"key":"8154_CR17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s11926-001-0032-3","volume":"3","author":"D Tanne","year":"2001","unstructured":"Tanne D, Hassin-Baer S (2001) Neurologic manifestations of the antiphospholipid syndrome. Curr Rheumatol Rep 3:286\u2013292","journal-title":"Curr Rheumatol Rep"},{"key":"8154_CR18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1006\/jaut.1994.1032","volume":"7","author":"M Blank","year":"1994","unstructured":"Blank M, Faden D, Tincani A, Kopolovic J, Goldberg I, Gilburd B et al (1994) Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J Autoimmun 7:441\u2013455","journal-title":"J Autoimmun"},{"key":"8154_CR19","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1172\/JCI115927","volume":"90","author":"AE Gharavi","year":"1992","unstructured":"Gharavi AE, Sammaritano LR, Wen J, Elkon KB (1992) Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H). J Clin Invest 90:1105\u20131109","journal-title":"J Clin Invest"},{"key":"8154_CR20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1191\/096120301678416060","volume":"10","author":"A Katzav","year":"2001","unstructured":"Katzav A, Pick CG, Korczyn AD, Oest E, Blank M, Shoenfeld Y et al (2001) Hyperactivity in a mouse model of the antiphospholipid syndrome. Lupus 10:496\u2013499","journal-title":"Lupus"},{"key":"8154_CR21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bbr.2006.01.015","volume":"169","author":"A Katzav","year":"2006","unstructured":"Katzav A, Litvinjuk Y, Pick CG, Blank M, Shoenfeld Y, Sirota P et al (2006) Genetic and immunological factors interact in a mouse model of CNS antiphospholipid syndrome. Behav Brain Res 169:289\u2013293","journal-title":"Behav Brain Res"},{"key":"8154_CR22","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1191\/0961203302lu255oa","volume":"11","author":"S Shrot","year":"2002","unstructured":"Shrot S, Katzav A, Korczyn AD, Litvinju Y, Hershenson R, Pick CG et al (2002) Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies. Lupus 11:736\u2013743","journal-title":"Lupus"},{"key":"8154_CR23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1172\/JCI119572","volume":"100","author":"L Ziporen","year":"1997","unstructured":"Ziporen L, Shoenfeld Y, Levy Y, Korczyn AD (1997) Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model. J Clin Invest 100:613\u2013619","journal-title":"J Clin Invest"},{"key":"8154_CR24","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1191\/0961203303lu409oa","volume":"12","author":"Y Shoenfeld","year":"2003","unstructured":"Shoenfeld Y, Nahum A, Korczyn AD, Dano M, Rabinowitz R, Beilin O et al (2003) Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 12:436\u2013442","journal-title":"Lupus"},{"key":"8154_CR25","first-page":"38","volume":"36","author":"P Nowacki","year":"1998","unstructured":"Nowacki P, Ronin-Walknowska E, Ossowicka-Stepinska J (1998) Central nervous system involvement in pregnant rabbits with experimental model of antiphospholipid syndrome. Folia Neuropathol 36:38\u201344","journal-title":"Folia Neuropathol"},{"key":"8154_CR26","first-page":"269","volume":"37","author":"P Nowacki","year":"1999","unstructured":"Nowacki P, Ronin-Walknowska E, Ossowicka-Stepinska J (1999) Neuropathological changes within the brain of rabbits with experimental model of antiphospholipid syndrome in different time after immunization. Folia Neuropathol 37:269\u2013272","journal-title":"Folia Neuropathol"},{"key":"8154_CR27","first-page":"15","volume":"43","author":"P Nowacki","year":"2005","unstructured":"Nowacki P, Ossowicka-Stepinska J, Ronin-Walkanowska E, Tabaka J (2005) The antiphospholipid syndrome in pregnant rabbits and their offspring. Neuropathological aspects. Folia Neuropathol 43:15\u201322","journal-title":"Folia Neuropathol"},{"key":"8154_CR28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/10446670410001670526","volume":"11","author":"L Ziporen","year":"2004","unstructured":"Ziporen L, Polak-Charcon S, Korczyn DA, Goldberg I, Afek A, Kopolovic J et al (2004) Neurological dysfunction associated with antiphospholipid syndrome: histopathological brain findings of thrombotic changes in a mouse model. Clin Dev Immunol 11:67\u201375","journal-title":"Clin Dev Immunol"},{"key":"8154_CR29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.nbd.2007.12.004","volume":"30","author":"D Tanne","year":"2008","unstructured":"Tanne D, Katzav A, Beilin O, Grigoriadis NC, Blank M, Pick CG et al (2008) Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome. Neurobiol Dis 30:56\u201364","journal-title":"Neurobiol Dis"},{"key":"8154_CR30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.expneurol.2005.11.017","volume":"198","author":"M Castro Ribeiro de","year":"2006","unstructured":"de Castro Ribeiro M, Badaut J, Price M, Meins M, Bogousslavsky J, Monard D et al (2006) Thrombin in ischemic neuronal death. Exp Neurol 198:199\u2013203","journal-title":"Exp Neurol"},{"key":"8154_CR31","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1523\/JNEUROSCI.3665-07.2008","volume":"28","author":"N Maggio","year":"2008","unstructured":"Maggio N, Shavit E, Chapman J, Segal M (2008) Thrombin induces long-term potentiation of reactivity to afferent stimulation and facilitates epileptic seizures in rat hippocampal slices: toward understanding the functional consequences of cerebrovascular insults. J Neurosci 28:732\u2013736","journal-title":"J Neurosci"},{"key":"8154_CR32","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1161\/hs0901.095408","volume":"32","author":"M Xue","year":"2001","unstructured":"Xue M, Del Bigio MR (2001) Acute tissue damage after injections of thrombin and plasmin into rat striatum. Stroke 32:2164\u20132169","journal-title":"Stroke"},{"key":"8154_CR33","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1097\/00001756-200108080-00013","volume":"12","author":"O Beilin","year":"2001","unstructured":"Beilin O, Gurwitz D, Korczyn AD, Chapman J (2001) Quantitative measurements of mouse brain thrombin-like and thrombin inhibition activities. NeuroReport 12:2347\u2013251","journal-title":"NeuroReport"},{"key":"8154_CR34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/jnr.20270","volume":"79","author":"O Beilin","year":"2005","unstructured":"Beilin O, Karussis DM, Korczyn AD, Gurwitz D, Aronovich R, Hantai D et al (2005) Increased thrombin inhibition in experimental autoimmune encephalomyelitis. J Neurosci Res 79:351\u2013359","journal-title":"J Neurosci Res"},{"key":"8154_CR35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/WNR.0b013e328091c1e6","volume":"18","author":"O Beilin","year":"2007","unstructured":"Beilin O, Karussis DM, Korczyn AD, Gurwitz D, Aronovich R, Mizrachi-Kol R et al (2007) Increased KPI containing amyloid precursor protein in experimental autoimmune encephalomyelitis brains. NeuroReport 18:581\u2013584","journal-title":"NeuroReport"},{"key":"8154_CR36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/jaut.1998.0214","volume":"11","author":"B Caronti","year":"1998","unstructured":"Caronti B, Calderaro C, Alessandri C, Conti F, Tinghino R, Pini C et al (1998) Serum anti-beta2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells. J Autoimmun 11:425\u2013429","journal-title":"J Autoimmun"},{"key":"8154_CR37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-510X(98)00027-6","volume":"156","author":"B Caronti","year":"1998","unstructured":"Caronti B, Pittoni V, Palladini G, Valesini G (1998) Anti-beta 2-glycoprotein I antibodies bind to central nervous system. J Neurol Sci 156:211\u2013219","journal-title":"J Neurol Sci"},{"key":"8154_CR38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1191\/096120399678847524","volume":"8","author":"J Chapman","year":"1999","unstructured":"Chapman J, Cohen-Armon M, Shoenfeld Y, Korczyn AD (1999) Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus 8:127\u2013133","journal-title":"Lupus"},{"key":"8154_CR39","first-page":"1725","volume":"24","author":"M Kent","year":"1997","unstructured":"Kent M, Alvarez F, Vogt E, Fyffe R, Ng AK, Rote N (1997) Monoclonal antiphosphatidylserine antibodies react directly with feline and murine central nervous system. J Rheumatol 24:1725\u20131733","journal-title":"J Rheumatol"},{"key":"8154_CR40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/exnr.2000.7358","volume":"163","author":"MN Kent","year":"2000","unstructured":"Kent MN, Alvarez FJ, Ng AK, Rote NS (2000) Ultrastructural localization of monoclonal antiphospholipid antibody binding to rat brain. Exp Neurol 163:173\u2013179","journal-title":"Exp Neurol"},{"key":"8154_CR41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1568-9972(01)00014-3","volume":"1","author":"PL Meroni","year":"2002","unstructured":"Meroni PL, Raschi E, Testoni C (2002) Endothelium as a target for anti-phospholipid antibodies and for therapeutical intervention. Autoimmun Rev 1:55\u201360","journal-title":"Autoimmun Rev"},{"key":"8154_CR42","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0028-1082267","volume":"34","author":"SS Pierangeli","year":"2008","unstructured":"Pierangeli SS, Chen PP, Raschi E, Scurati S, Grossi C, Borghi MO et al (2008) Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms. Semin Thromb Hemost 34:236\u2013250","journal-title":"Semin Thromb Hemost"},{"key":"8154_CR43","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/rheumatology\/ken349","volume":"47","author":"P Soltesz","year":"2008","unstructured":"Soltesz P, Der H, Veres K, Laczik R, Sipka S, Szegedi G et al (2008) Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction. Rheumatology (Oxford) 47:1628\u20131634","journal-title":"Rheumatology (Oxford)"},{"key":"8154_CR44","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.imbio.2005.10.010","volume":"210","author":"R Aronovich","year":"2005","unstructured":"Aronovich R, Gurwitz D, Kloog Y, Chapman J (2005) Antiphospholipid antibodies, thrombin and LPS activate brain endothelial cells and Ras-dependent pathways through distinct mechanisms. Immunobiology 210:781\u2013788","journal-title":"Immunobiology"},{"key":"8154_CR45","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2174\/092986707780090945","volume":"14","author":"M Todorova","year":"2007","unstructured":"Todorova M, Baleva M (2007) Some recent insights into the prothrombogenic mechanisms of antiphospholipid antibodies. Curr Med Chem 14:811\u2013826","journal-title":"Curr Med Chem"},{"key":"8154_CR46","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/art.21009","volume":"52","author":"M Vega-Ostertag","year":"2005","unstructured":"Vega-Ostertag M, Casper K, Swerlick R, Ferrara D, Harris EN, Pierangeli SS (2005) Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. Arthritis Rheum 52:1545\u20131554","journal-title":"Arthritis Rheum"},{"key":"8154_CR47","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1055\/s-0037-1614108","volume":"84","author":"FM Williams","year":"2000","unstructured":"Williams FM, Parmar K, Hughes GR, Hunt BJ (2000) Systemic endothelial cell markers in primary antiphospholipid syndrome. Thromb Haemost 84:742\u2013746","journal-title":"Thromb Haemost"},{"key":"8154_CR48","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4049\/jimmunol.174.1.485","volume":"174","author":"J Berman","year":"2005","unstructured":"Berman J, Girardi G, Salmon JE (2005) TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss. J Immunol 174:485\u2013490","journal-title":"J Immunol"},{"key":"8154_CR49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1191\/0961203305lu2048oa","volume":"14","author":"RR Forastiero","year":"2005","unstructured":"Forastiero RR, Martinuzzo ME, de Larranaga GF (2005) Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies. Lupus 14:129\u2013136","journal-title":"Lupus"},{"key":"8154_CR50","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/art.21549","volume":"54","author":"C Lopez-Pedrera","year":"2006","unstructured":"Lopez-Pedrera C, Buendia P, Cuadrado MJ, Siendones E, Aguirre MA, Barbarroja N et al (2006) Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB\/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1\/ERK pathway. Arthritis Rheum 54:301\u2013311","journal-title":"Arthritis Rheum"},{"key":"8154_CR51","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1538-7836.2007.02680.x","volume":"5","author":"ME Vega-Ostertag","year":"2007","unstructured":"Vega-Ostertag ME, Ferrara DE, Romay-Penabad Z, Liu X, Taylor WR, Colden-Stanfield M et al (2007) Role of p38 mitogen-activated protein kinase in antiphospholipid antibody-mediated thrombosis and endothelial cell activation. J Thromb Haemost 5:1828\u20131834","journal-title":"J Thromb Haemost"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-009-8154-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-009-8154-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-009-8154-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:48:45Z","timestamp":1559425725000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-009-8154-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,26]]},"references-count":51,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["8154"],"URL":"https:\/\/doi.org\/10.1007\/s12016-009-8154-x","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,26]]}}}